Azora Therapeutics, Inc.
AZRHealthcare|Medical - Pharmaceuticals|US
$4.00
+0.29 (+7.82%)
Earnings History
Next report: Nov 18, 2026 · EPS est. $-0.30| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Aug 17, 2026 | $-11.25 | $-1.03 | — | — |
| May 11, 2026 | $-1.48 | $-2.73 | — | — |
| Mar 6, 2026 | $-1.81 | $-2.13 | — | — |
| Nov 14, 2025 | $-2.00 | $-3.50 | — | — |
| Aug 13, 2025 | $-4.50 | $-5.50 | — | — |
| May 15, 2025 | $-8.50 | $-12.38 | — | — |
| Mar 4, 2025 | $-8.00 | $-9.69 | — | — |
| Nov 13, 2024 | $-9.50 | $-10.00 | — | — |
News
Azora Therapeutics Appoints Board of Directors with Extensive Drug Development and Inflammatory Bowel Disease Expertise
LOS ANGELES, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Azora Therapeutics, Inc. (Nasdaq: AZR), a biopharmaceutical company developing treatments for serious inflammatory diseases, today announced it has established a five-member board of directors with deep drug development experience, a track record of FDA approvals, expertise in public-company governance, and clinical capabilities in gastroenterology and immunology. “The depth and diversity of expertise represented in our board of directors position A…
Nov 5, 2026globenewswire.com